CRDL
Cardiol Therapeutics Inc Class A
NASDAQ: CRDL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.38
+5.34% today
Updated 2026-04-30
Market cap
$156.35M
P/E ratio
—
P/S ratio
1,014.87x
EPS (TTM)
$-0.29
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
Cardiol Therapeutics Inc Class A (CRDL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |